Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Am Podiatr Med Assoc ; 108(1): 12-19, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29547036

RESUMO

Onychomycosis is a fungal infection of the nail primarily caused by the dermatophytes Trichophyton rubrum and Trichophyton mentagrophytes. The topical-based treatment of onychomycosis remains a challenge because of the difficulty associated with penetrating the dense, protective structure of the keratinized nail plate. Tavaborole is a novel small-molecule antifungal agent recently approved in the United States for the topical treatment of toenail onychomycosis. The low molecular weight, slight water solubility, and boron chemistry of tavaborole maximize nail penetration after topical application, allowing for effective targeting of the infection in the nail bed. The efficacy of tavaborole is associated with its novel mechanism of action, whereby it inhibits the fungal leucyl-tRNA synthetase (LeuRS) enzyme. Because LeuRS is an essential component in fungal protein synthesis, inhibition of LeuRS ultimately leads to fungal cell death. Tavaborole is the first boron-based antifungal medication approved for the treatment of mild-to-moderate onychomycosis and presents patients with a new topical option. Previously, ciclopirox and efinaconazole were the only approved topical treatments for onychomycosis. This article details the properties that are at the core of the clinical benefits associated with tavaborole.


Assuntos
Compostos de Boro/farmacocinética , Compostos Bicíclicos Heterocíclicos com Pontes/farmacocinética , Onicomicose/tratamento farmacológico , Humanos , Testes de Sensibilidade Microbiana , Unhas/efeitos dos fármacos , Unhas/microbiologia , Onicomicose/metabolismo , Resultado do Tratamento
2.
Ther Deliv ; 9(2): 99-119, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-29325509

RESUMO

AIM: The present investigation's intention was to develop an optimized nail lacquer (NL) for the management of onychomycosis. MATERIALS & METHODS: The NL was optimized statistically adopting 32 full factorial design having different polymer ratios and solvent ratios. The formulations were assessed for drug permeation drying time and peak adhesive strength of the film. Characterization was done using techniques including attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR), scanning electron microscopy (SEM), differential scanning calorimetry (DSC), x-ray diffraction (XRD), etc. RESULTS & CONCLUSION: The formulation that had 1:1 polymer ratio and 80:20 solvent ratio was chosen as the optimized formulation. In vitro permeation studies showed better penetration (∼3.25-fold) as well as retention (∼11-fold) of the optimized NL formulation in the animal hoof as compared with the commercial formulation. The findings of in vitro and ex vivo studies elucidated the potential of the optimized formulation. [Formula: see text].


Assuntos
Antifúngicos/metabolismo , Gerenciamento Clínico , Composição de Medicamentos/métodos , Laca , Onicomicose/metabolismo , Terbinafina/metabolismo , Animais , Antifúngicos/administração & dosagem , Antifúngicos/síntese química , Candida albicans , Avaliação Pré-Clínica de Medicamentos/métodos , Casco e Garras/efeitos dos fármacos , Casco e Garras/metabolismo , Casco e Garras/patologia , Onicomicose/tratamento farmacológico , Onicomicose/patologia , Terbinafina/administração & dosagem , Terbinafina/síntese química , Difração de Raios X
3.
Br J Dermatol ; 157(3): 494-500, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17627796

RESUMO

BACKGROUND: Topical treatment of nail diseases is hampered by the nail plate barrier, consisting of dense cross-linked keratin fibres held together by cysteine-rich proteins and disulphide bonds, which prevents penetration of antifungal agents to the focus of fungal infection. Acidified nitrite is an effective treatment for tinea pedis. It releases nitric oxide (NO) and other NO-related species. NO can react with thiol (-SH) groups to form nitrosothiols (-SNO). OBJECTIVES: To determine whether acidified nitrite can penetrate the nail barrier and cure onychomycosis, and to determine whether nitrosospecies can bind to the nail plate. METHODS: Nails were treated with a mixture of citric acid and sodium nitrite in a molar ratio of 0.54 at either low dose (0.75%/0.5%) or high dose (13.5%/9%). Immunohistochemistry, ultraviolet-visible absorbance spectroscopy and serial chemical reduction of nitrosospecies followed by chemiluminescent detection of NO were used to measure nitrosospecies. Acidified nitrite-treated nails and the nitrosothiols S-nitrosopenicillamine (SNAP) and S-nitrosoglutathione (GSNO) were added to Trichophyton rubrum and T. mentagrophytes cultures in liquid Sabouraud medium and growth measured 3 days later. Thirteen patients with positive mycological cultures for Trichophyton or Fusarium species were treated with topical acidified nitrite for 16 weeks. Repeat mycological examination was performed during this treatment time. RESULTS: S-nitrothiols were formed in the nail following a single treatment of low- or high-dose sodium nitrite and citric acid. Repeated exposure to high-dose acidified nitrite led to additional formation of N-nitrosated species. S-nitrosothiol formation caused the nail to become antifungal to T. rubrum and T. mentagrophytes. Antifungal activity was Cu(2+) sensitive. The nitrosothiols SNAP and GSNO were also found to be antifungal. Topical acidified nitrite treatment of patients with onychomycosis resulted in > 90% becoming culture negative for T. rubrum. CONCLUSIONS: Acidified nitrite cream results in the formation of S-nitrosocysteine throughout the treated nail. Acidified nitrite treatment makes a nail antifungal. S-nitrosothiols, formed by nitrosation of nail sulphur residues, are the active component. Acidified nitrite exploits the nature of the nail barrier and utilizes it as a means of delivery of NO/nitrosothiol-mediated antifungal activity. Thus the principal obstacle to therapy in the nail becomes an effective delivery mechanism.


Assuntos
Antifúngicos/uso terapêutico , Ácido Cítrico/administração & dosagem , Unhas/efeitos dos fármacos , Onicomicose/tratamento farmacológico , Nitrito de Sódio/administração & dosagem , Administração Tópica , Adulto , Idoso , Antifúngicos/farmacocinética , Ácido Cítrico/farmacocinética , Cisteína/análogos & derivados , Cisteína/farmacocinética , Combinação de Medicamentos , Feminino , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Unhas/fisiologia , Óxido Nítrico/farmacocinética , Pomadas , Onicomicose/metabolismo , S-Nitrosotióis/farmacocinética , Nitrito de Sódio/farmacocinética , Fatores de Tempo , Trichophyton
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA